Schedule 13D ownership disclosure
CATALYST BIOSCIENCES, INC.
Security class unavailable · CUSIP: 14888D109
Event date: 2015-08-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-15-308107
- Form type
- SC 13D
- Filer
- GYRE THERAPEUTICS, INC.
- CIK
- CIK 1124105
- Filed
- Aug 31, 2015
- Reporting period
- Aug 20, 2015
- Description
- Schedule 13D beneficial ownership